Scholars Central

Review articlePublished 31 Aug 2022

Stereochemistry and Its Role in Drug Design

Authors: Myle Akshay Kiran

Clinical Pharmacology & Biopharmaceutics

Volume 11 · Issue 8 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

When designing small motes to interact with the targets, one should consider stereos electivity. As considerations for exploring structure space evolve, chirality is decreasingly important. List affinity for a chiral medicine can differ for diastereomers and between enantiomers. For the virtual webbing and computational design stage of medicine development, this problem can be compounded by deficient stereo chemical information in structure libraries leading to a

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Pharmacology & Biopharmaceutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Pharmacology & Biopharmaceutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Myle Akshay Kiran”